Precision NanoSystems, now part of Cytiva, is a global leader in technologies, solutions, and services for the development of genomic medicines. Headquartered in Vancouver, Canada, the company accelerates the development of mRNA–LNP formulations by using their proprietary NanoAssemblr instrument. Their complete, end-to-end LNP formulation services and GMP manufacturing include formulation development, process development, scale-up, CMC support, bioassay development, and analytical support.